Benjamin T Diamond, Md

This study tests a combination of four drugs (iberdomide, daratumumab, carfilzomib, and dexamethasone) in adults whose multiple myeloma has come back or stopped responding to earlier treatments. The goal is to see if this mix can shrink the cancer to very low levels and keep it f…